Sign in
4

Changes in Ownership

Opus Genetics, Inc. Filed Acc 0001140361-16-049547

Options or other derivatives

  • Chief Medical Officer acquired 598,734 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Benaim Ely · Chief Medical Officer

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-01-28 Grant or award : show line 1 in the form Stock Option (right to buy) +98,734 $0.35 2026-01-28 98,734 98,734 D
2016-01-28 Grant or award : show line 2 in the form Stock Option (right to buy) +500,000 $0.35 2026-01-28 500,000 500,000 D
Loading xslF345X03/doc1.xml…